Piper Sandler Cuts Globe Life (GL) Price Target to $165
Key Points
- Piper Sandler lowered its rating on Globe Life Inc. to Neutral and cut its price target to $165.00 on October 23, 2026.
- Piper Sandler's $165 price target implies 2.72% downside from Globe Life Inc.'s ($GL) current $169.62 share price.
- Globe Life recently traded around $169.62, sitting well below its 52-week high of $191.55.
- Other major Wall Street firms including Wells Fargo and JP Morgan maintain positive ratings on the insurer.
Get Globe Life text alerts
We text you when insiders, Congress, analysts or big funds move on $GL.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures
On October 23, 2026, Piper Sandler adjusted its outlook on Globe Life Inc. NYSE: GL, lowering its rating on the insurance provider to Neutral from previous coverage. According to the research note released on October 23, 2026, the firm reduced its price target to $165.00 from $200.00. The move comes as Wall Street weighs near-term headwinds against the insurer's fundamental position.
GL
Globe Life Inc.
Piper Sandler vs. the S&P 500
Hypothetical returns from Piper Sandler's disclosed trades, not real profit or advice. How we model this.
Piper Sandler's Call on Globe Life
In its research note on October 23, 2026, Piper Sandler lowered the stock to a Neutral rating and brought its price target down to $165.00 from its prior target of $200.00. Analyst ratings reflect forward-looking perspectives on a company's business model and profit outlook. Globe Life recently traded at $169.62, putting the new target slightly below the current share price.
Other Institutional Activity in Globe Life
AQR Capital Management, LLC grew its holdings by 318,052 shares, ending with 1,515,987 shares worth about $255,307,376.00. Nuveen, LLC reduced its holdings by 2,248 shares, ending with 1,496,640 shares worth about $252,049,147.00.
Globe Life Inc. Stock Holds Steady
Globe Life shares recently traded around $169.62, up about 0.7% from an event-day close of $168.41 on October 22, 2026. The stock sits 0.6% below its 50-day moving average of $170.58 and 6.5% above its 200-day moving average of $159.22. Shares trade 11.4% below their 52-week high of $191.55 and 32.7% above their 52-week low of $127.85.
$GL price target
Globe Life Inc. daily closes and this analyst's $165 target. Not advice.
Recent Earnings
Globe Life generated trailing-twelve-month revenue of $6,274,907,136.00 with earnings of $14.94 per share. The insurer posted a net profit margin of 18.9% and a return on equity pointing to solid operational efficiency. The company is expected to release its next set of financial results on February 3, 2027.
Dividend
Globe Life pays an annual dividend rate of $1.32 per share, which translates to a dividend yield of 0.78%. The payout ratio sits at 8.0%, leaving plenty of earnings retained to support core operations and capital growth.
Insider Buying and Selling at Globe Life Inc.
Corporate insiders have actively adjusted their holdings over recent months. On July 29, 2026, officer Michael Clay Majors sold 37,000 shares for a total value of $6,609,525.00. Chief financial officer Thomas Peter Kalmbach sold 21,000 shares on July 30, 2026, valued at $3,781,162.00. Chief executive officer James Matthew Darden sold 50,000 shares on July 31, 2026, worth $9,121,638.00. Later, on September 22, 2026, chief investment officer Robert Edward Hensley sold 10,000 shares for a total value of $1,700,701.00.
Analysts Set New Price Targets
Keefe, Bruyette & Woods maintained an Outperform rating on July 24, 2026, adjusting its price target to $190.00 from $192.00. Morgan Stanley maintained an Overweight rating on October 5, 2026, moving its target to $197.00 from $208.00. Wells Fargo maintained an Overweight rating on October 12, 2026, lifting its target to $191.00 from $190.00. JP Morgan maintained an Overweight rating on October 15, 2026, raising its target to $195.00 from $193.00. Overall, the stock carries a consensus buy recommendation across 11 analyst opinions, with a mean target price of $192.09.
About Globe Life
Globe Life Inc. provides life and supplemental health insurance products aimed at lower middle- and middle-income families across the United States. The company operates through life insurance, supplemental health insurance, and investment segments. Headquartered in McKinney, Texas, the firm relies on a vast network of independent agents and direct-response marketing to reach everyday households.
Bottom Line
Piper Sandler's downgrade to a Neutral rating introduces a cautious note following a series of insider transactions and previous target adjustments from peers. Investors will monitor upcoming earnings reports on February 3, 2027, to see how the insurer navigates ongoing market conditions.
Related Filing Alerts
Source: Piper Sandler's rating change on $GL (Oct 23, 2026). Written by software, not financial advice. How we make alerts